| Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
|---|
| 05/31/2000 | EP1003785A1 Methods for the isolation of proteinase inhibitor proteins from potato tubers |
| 05/31/2000 | EP1003781A1 Interleukin-18 binding proteins, their preparation and use |
| 05/31/2000 | EP1003772A1 Chemical modification of proteins to improve biocompatibility and bioactivity |
| 05/31/2000 | EP1003540A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
| 05/31/2000 | EP1003480A1 Conjugated peptide nucleic acids having enhanced cellular uptake |
| 05/30/2000 | US6069236 Desalting, chromatography on anion exchange gel, viral deactivation using solvent-detergent treatment, chromatography on cation exchange gel, recovering; does not cause aggregate-induced complement activation |
| 05/30/2000 | US6069128 Low molecular weight peptide corresponding to transmembrane region of interleukin-8 protein, transformed into its acetoxymethyl ester counterpart and converted back to orginal form via intracellular esterase; treating inflammation |
| 05/30/2000 | US6069127 Human infant formula containing a glycoprotein specific for binding to the human mac-2 (macrophage antigen) lectin; to prevent infections |
| 05/30/2000 | US6068818 Electronic device for performing active biological operations; and methods for manufacture of such devices containing active electrodes especially adapted for electrophoretic transport of nucleic acids, their hybridization and analysis |
| 05/30/2000 | CA2083333C High dosage topical forms of collagenase |
| 05/30/2000 | CA2026570C Method for production and purification of hepatitis b vaccine |
| 05/25/2000 | WO2000029851A1 A method for determining a mimotope sequence |
| 05/25/2000 | WO2000029617A2 Water-soluble luminescent quantum dots and bioconjugates thereof |
| 05/25/2000 | WO2000029440A1 Methods of conversion of interferon isoforms and products thereof |
| 05/25/2000 | WO2000015605A3 Chiral cyanoamines and methods of preparation |
| 05/25/2000 | WO2000009543A3 Hepatitis c inhibitor tri-peptides |
| 05/24/2000 | EP1002288A2 Method of determining protein-ligand interactions via computer modeling |
| 05/24/2000 | EP1002066A1 Composition and method for regulating the adhesion of cells and biomolecules to hydrophobic surfaces |
| 05/24/2000 | EP1001970A1 Dipeptide derivatives as growth hormone secretagogues |
| 05/24/2000 | EP1001968A1 Solid phase native chemical ligation of unprotected or n-terminal cysteine protected peptides in aqueous solution |
| 05/24/2000 | EP1001839A1 Hollow fiber co-flow filtration device |
| 05/24/2000 | EP1001800A2 Biologically active peptides with reduced toxicity in animals and a method for preparing same |
| 05/24/2000 | EP1001797A1 Soya extract, process for its preparation and pharmaceutical composition |
| 05/24/2000 | EP0858463A4 Alcohol-free wet extraction of gluten dough into gliadin and glutenin |
| 05/24/2000 | EP0804070B1 Process of isolation of proteins from milk |
| 05/24/2000 | EP0720620B1 Glutathione analogs and paralog panels comprising glutathione mimics |
| 05/24/2000 | CN1254379A Methods of production of amidated peptide through use of fusion protein |
| 05/24/2000 | CN1254284A Activated protein C formulations |
| 05/23/2000 | US6066719 Immunoglobulin heavy chain fragment associated with two light chains which each comprise a variable domain and form two functional antigen binding positions; for use in isolation of antibodies |
| 05/23/2000 | US6066481 Simple, inexpensive, efficient, environmently friendly process by treating the protein-containing solution with a salt containing a sulphur atom having an oxidation state less than 6, and recovering the protein |
| 05/23/2000 | US6066470 Method for removing N-terminal methionine |
| 05/23/2000 | CA2062732C A mutated subtilisin protease |
| 05/23/2000 | CA2006818C Insulin derivatives, a process for the preparation thereof, the use thereof and a pharmaceutical formulation containing them |
| 05/18/2000 | WO2000027878A1 Screening system for zinc finger polypeptides for a desired binding ability |
| 05/18/2000 | WO2000027869A1 Methods of purifying recombinant human erythropoietin from cell culture supernatants |
| 05/18/2000 | WO2000027814A1 Avidin derivatives and uses thereof |
| 05/18/2000 | WO2000009725A3 Method for recovering proteins from the interstitial fluid of plant tissues |
| 05/18/2000 | WO1999024470A8 Mammalian milk growth factor |
| 05/18/2000 | DE19940749A1 Integrated synthesis and analysis method e.g. for polymers, comprises a carrier body provided with immobilized receptors to provide respective channels before contact with sample and subsequent analysis |
| 05/18/2000 | CA2704598A1 Methods of purifying recombinant human erythropoietin from cell culture supernatants |
| 05/18/2000 | CA2350827A1 Screening system for zinc finger polypeptides for a desired binding ability |
| 05/17/2000 | EP1000085A1 Treatment of insulin resistance with growth hormone secretagogues |
| 05/17/2000 | EP1000081A2 A reversible stoichiometric process for conjugating biomolecules |
| 05/17/2000 | EP0785920B1 Multifunctional cross-linking reagents for hemoglobin, and cross-linked hemoglobin conjugates |
| 05/17/2000 | EP0773950A4 Linked peptide nucleic acids |
| 05/17/2000 | EP0703922B1 Method for producing immunoglobulin g concentrate |
| 05/17/2000 | CN1253566A Active substance and composition inhibiting tumorous proliferation in ectoderm derived tissues |
| 05/17/2000 | CN1253019A Method for preparing medicine composition capable of inhibiting post infective virus proteinase |
| 05/16/2000 | US6063910 Bringing droplets of liquid protein solution in a solvent into contact at controlled rate with excess of supercritical antisolvent which dissolves and expands liquid solution and precipitates dry protein particles; for time-release drugs |
| 05/16/2000 | US6063909 Preparation of factor IX |
| 05/16/2000 | CA2165561C Peralkylated oligopeptide mixtures |
| 05/16/2000 | CA2157358C Purification of human interleukin-10 |
| 05/16/2000 | CA2113660C Process for the obtention of biological adhesive made of concentrated coagulation factors by salting-out |
| 05/16/2000 | CA2090701C Solubilization of proteins in active forms |
| 05/11/2000 | WO2000026370A2 Adenine nucleotide translocator (ant) fusion proteins and uses thereof |
| 05/11/2000 | WO2000026239A2 $i(chlamydia) antigens and corresponding dna fragments and uses thereof |
| 05/11/2000 | WO2000026238A2 Biological materials and methods useful in the diagnosis and treatment of prion diseases |
| 05/11/2000 | DE19940810A1 Biochemical analysis instrument uses mixture of sample and smart reagent beads viewed by color CCD camera to perform chemical analysis of medical samples. |
| 05/11/2000 | CA2349504A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/11/2000 | CA2349444A1 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor |
| 05/11/2000 | CA2348751A1 Biological materials and methods useful in the diagnosis and treatment of diseases |
| 05/10/2000 | EP0998486A1 Protein recovery by chromatography followed by filtration upon a charged layer |
| 05/10/2000 | EP0998485A1 Refolding method using a foldase and a chaperone |
| 05/10/2000 | EP0708943B1 Method for designing molecules with desired properties by evolving successive populations |
| 05/10/2000 | EP0649533B1 Reagents and methods for the detection and quantification of thyroxine in fluid samples |
| 05/10/2000 | CN2377250Y External pressure type hollow fibre column |
| 05/10/2000 | CN1252807A Neoglycoproteins |
| 05/10/2000 | CN1252408A Serial animal globulin foods and their production process |
| 05/10/2000 | CN1252407A Cassia protein extracting process |
| 05/10/2000 | CN1052240C Method for preparing inhibitor of retroinfection viral protease |
| 05/10/2000 | CN1052239C Method for preparation of NTPS |
| 05/09/2000 | US6061636 Technique for representing combinatorial chemistry libraries resulting from selective combination of synthons |
| 05/09/2000 | US6060586 Ureins derived from alpha, omega-diamono acids and process for their preparation |
| 05/09/2000 | US6060293 Resonance driven changes in chain molecule structure |
| 05/09/2000 | US6060259 Having molecular weight in presence of sodium dodecyl sulfate of between 44.5 and 47.5 kilodaltons; for detecting or monitoring the development of tuberculosis in man or cattle |
| 05/09/2000 | US6060071 Ectoin and ectoin derivatives as moisturizers in cosmetics |
| 05/09/2000 | CA2100586C Htlv-i and htlv-ii peptide antigens and methods |
| 05/09/2000 | CA2062340C Process for the industrial-scale preparation of a highly pure standardized human von willebrand factor concentrate appropriate for therapeutic use |
| 05/09/2000 | CA2058940C Targeted liposomes and methods for liposome-protein coupling |
| 05/09/2000 | CA2014222C A process for removing toxins from protein solutions |
| 05/09/2000 | CA1340985C Peptide derivatives |
| 05/04/2000 | WO2000024922A1 Method for producing in vivo proteins chemically diversified by incorporating non-standard amino acids |
| 05/04/2000 | WO2000024910A1 Process of purification of low density lipoprotein associated phospholipase a2 using immobilized metal affinity chromatography |
| 05/04/2000 | WO2000024902A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/04/2000 | WO2000024901A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/04/2000 | WO2000024697A1 Method for preparation of polyethylene glycol aldehyde derivatives |
| 05/04/2000 | WO1999064038A9 Novel analgesic agents |
| 05/04/2000 | WO1999064031A9 β2-ADRENERGIC RECEPTOR AGONISTS |
| 05/04/2000 | WO1999058476A9 Method and device for nonsynthetic deconvolution |
| 05/04/2000 | CA2348989A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/04/2000 | CA2348747A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/04/2000 | CA2347993A1 Method for producing in vivo proteins chemically diversified by incorporating non-standard amino acids |
| 05/03/2000 | EP0997459A1 Intermediates for preparing retroviral protease inhibiting compounds |
| 05/03/2000 | EP0996635A1 Novel family of pheromone receptors |
| 05/03/2000 | EP0996627A1 Method for solution phase synthesis of oligonucleotides and peptides |
| 05/03/2000 | EP0776334A4 Stable analogs of bioactive peptides containing disulfide linkages |
| 05/03/2000 | EP0560947B1 Trivalent monospecific antigen binding proteins |
| 05/03/2000 | EP0383803B1 Oligonucleotide-polyamide conjugates |
| 05/02/2000 | US6057430 Treating denatured monomers of transforming growth factor-beta 3 with a folding buffer of a mild detergent and dimethyl sulfoxide, dimethyl sulfone and/or dimethylformamide increases yield of active dimers |
| 05/02/2000 | US6057292 Method for inhibiting growth hormone action |